Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggression
akinetic mute
algorithm
alopecia
AMPA receptor antibodies
amphetamines
amphiphysin antibodies
analgesic
anesthesia, general
anesthesia, local
anti GQ1b IgG antibody
anti IgLON5
antibiotics
antibiotics, neurologic complications with
antibodies to voltage-gated calcium channels
anticholinesterase
anticonvulsants
anticonvulsants, blood level determination of
anticonvulsants, mechanism of action of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
antidepressant
antispasticity drugs
antithyroid antibodies
apnea
areflexia
arrhythmia, cardiac
ataxia
ataxia, cerebellar
attention deficit disorder with hyperactivity
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
automatic behavior
automobile accidents
autonomic dysfunction
baclofen
baclofen toxicity
baclofen withdrawal
basal ganglia
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
behavioral disorder, acute
benzodiazepine
beta adrenergic blocker
blindness
botulinum toxin
bradycardia
brain biopsy
Brueghel's syndrome
camphor
cannabinoids
carbamazepine
carcinoma
carcinoma of breast
carcinoma of lung
CAT scan, chest
catalepsy
catatonia
catecholamine
caudate nucleus
cerebral cortex
cerebral ischemia
cerebral palsy
cerebral palsy, associated problems with
cerebral palsy, etiology
cerebral palsy, risk factors
cerebral palsy, work up
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gamma amino butyric acid
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
channelopathy
children
chlorambucil
chloride channel dysfunction
chorea
chorea, treatment of
choreoathetosis
clonazepam
clonus
clozapine
cocaine
cognition
collapsin response mediator protein 5 IgG
coma
comorbidities
complications
confusion
contactin associated protein like 2 antibodies
contractures, joint
contrast agents, neurotoxicity of
controversies in neurology
cranial nerves, vascular compression
cyclosporine
dantrolene sodium
dementia
dementia, reversible
diabetes mellitus
diagnostic criteria
diarrhea
differential diagnosis
difficulty climbing stairs
dilantin
dilantin, serum level
dopamine
down-beat nystagmus
DPPX
DPPX, antibodies
DPPX, antibodies, encephalitis
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
drug withdrawal
dyskinesia
dyskinesia, facial
dystonia
dystonia musculorum deformens
dystonia, focal
dystonia, treatment of
electrocoagulation
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electromyogram
electromyogram, decremental response
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy
ephedrine
epidemiology of neurology
ergonovine
evidence-based research
exercise-related muscle strength increase
extralimbic encephalitis
facial pain
faciobrachial dystonic seizure
falling
false negative
familial
fever
flexor spasm
folic acid
gabapentin
gait disorder
gamma amino butyric acid
gamma amino butyric acid receptor antibody
gamma amino butyric acid-mimetic drug
gamma knife therapy
gamma loop mechanism
gammaglobulin therapy, intravenous
gender
genetic neurologic disorders
Gilles de la Tourette syndrome
glossopharyngeal neuralgia
glutamic acid
glutamic acid decarboxylase, antibody
glycine
glycine receptor antibodies
hallucination
hallucinosis
head injury
headache
hepatic encephalopathy
hepatic encephalopathy, treatment of
hepatitis
heralding manifestation
herpes simplex encephalitis
hiccoughs
hippocampus
HLA
Hodgkin's disease
homovanillic acid
Huntington's chorea
Huntington's chorea, presymptomatic detection of
hyperbaric oxygen
hyperbaric treatment
hyperekplexia
hypersomnia
hypertension
hypocretin
hyponatremia
hyporeflexia
hypotension, systemic
hypothalamus
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
immune reconstitution inflammatory syndrome
immunologic disease
immunosuppressive agents
immunotherapy
inattention
infantile spasm
infection
infusion pump
insomnia
intellectual deficit
intellectual deterioration
intrathecal antispasticity drugs
intrathecal pump
intubation
irritability
Isaacs syndrome
isoniazid
Jakob-Creutzfeldt disease
lamotrigine
L-dopa
leg spasms
leg spasms, painful
lethargy
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
lidocaine
life expectancy
limbic encephalitis
lordosis
lymphadenopathy, hilar
malignancy screen
mediastinum, mass of
memory
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
microdialysis
misdiagnosis
modafinil
monoamines
monoclonal antibodies
mortality
Morvan's fibrillary chorea
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, disappearing lesion on
MRI, FLAIR
MRI, indications for
MRI, negative
MRS
multiple sclerosis
multiple sclerosis, treatment of
multiple sleep latency test
muscimol
muscle cramp
muscle pain
muscle relaxant
muscle spasm
muscle stiffness
myasthenic syndrome
myelitis, transverse, recurrent
myoclonic jerks
myoclonus
myoclonus, cortical
myoclonus, segmental
nalidixic acid
narcolepsy
narcotic analgesics
nausea and vomiting
negative
neuralgia, treatment of
neurexin-3 alpha antibodies
neuroendocrinology
neurologic complications of, systemic cancer
neurologic disease, diagnoses of
neurologic disease, multifocal
neurolysis
neuronal cell surface antigen
neuronal loss
neurotoxin
neurotransmitter
NMDA antagonists
norepinephrine
nystagmus
nystagmus, periodic alternating
ophelia syndrome
ophthalmoplegia
organ transplantation
oscillopsia
pain
paraparesis, spastic
Parkinson disease
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
penicillin
personality change
phencyclidine poisoning
phenobarbital
phenylketonuria
phenylpropanolamine
physostigmine
pleocytosis of cerebrospinal fluid
polysomnogram
postural abnormality
potassium channel antibodies
practice guidelines
precipitating factors
prognosis
progressive neurologic disorder
propranolol
psychiatric problems in neurologic disorders
psychosis
pyridoxine deficiency
quality of life
rash
recurrent
reflex sympathetic dystrophy
REM sleep
remote effect of cancer on the nervous system
renal failure
repetitive nerve stimulation
respiratory failure
retinitis pigmentosa
review article
rhizotomy
rhizotomy, dorsal
rigidity
Riley-Day syndrome
rituximab
screening
seizure
seizure, adult onset
seizure, drug-induced
seizure, etiology of
seizure, familial
seizure, focal
seizure, intractable
seizure, minor motor
seizure, petit mal
seizure, psychomotor-temporal lobe
seizure, pyridoxine dependent
seizure, tonic-clonic
seizure, treatment of
seizure, unknown origin
seizure, withdrawal
serologic testing
serologic testing, false negative
seronegative
sleep offset paralysis
sleep onset paralysis
sleep paralysis
sleep pathology and physiology
sodium valproate
sodium valproate, toxicity
spastic diplegia
spasticity
spasticity, treatment of
spinal cord, injury of
spinal cord, injury, management of
spinocerebellar ataxia type 1
startle reaction
status epilepticus
status epilepticus, intractable
status epilepticus, nonconvulsive
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stiff legs
stiff limb syndrome
stiff man syndrome
stimulant drugs
stress, emotional
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
sympathomimetic drugs
tardive dyskinesia
tardive dyskinesia, treatment of
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
tone, muscle
tonic foot response
torticollis
trauma
treatment of neurologic disorder
tremor
trigeminal neuralgia
trigeminal neuralgia, etiology
trigeminal neuralgia, pathogenesis of
trigeminal neuralgia, surgical treatment of
trigeminal neuralgia, treatment of
undiagnosed
valium
vasospasm, cerebral
vigabatrin
vitamin K
weakness
weakness, fatiguable
weakness, progressive
weakness, proximal
weight gain
weight loss
wheelchair
white matter disease
white matter disease, subcortical
workup
xerostomia
Showing articles 100 to 150 of 1206 << Previous Next >>

Herpes Simplex Encephalitis as a Potential Cause of Anti-N-Methyl-D-Aspartate Receptor Antibody Encephalitis
JAMA Neurol 71:344-346, DeSena, A.,et al, 2014

Herpes Simplex Virus Encephalitis is a Trigger of Brain Autoimmunity
Ann Neurol 75:317-323, Armangue, T.,et al, 2014

Clinical Specificities of Adult Male Patients with NMDA Receptor Antibodies Encephalitis
Neurol 82:556-563, Viaccoz, A.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Late-Onset Anti-NMDA Receptor Encephalitis
Neurol 81:1058-1063, Titulaer, M.,et al, 2013

Frequency and Characteristics of Isolated Psychiatric Episodes in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
JAMA Neurol 70:1133-1139, Kayser, M.S.,et al, 2013

Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens
JNNP 84:748-755, Hacohen, Y.,et al, 2013

Extreme Delta Brush
Neurol 79:1094-1100, Schmitt, S.E.,et al, 2012

Central Nervous System Neuronal Surface Antibody Associated Syndromes: Review and Guidelines for Recognition
JNNP 83:638-645, Zuliani,L.,et al, 2012

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Memantine for Dementia in Adults Older than 40 years with Downs Syndrome (MEADOWS): a Randomised,double-blind,placebo-controlled Trial
Lancet 379:528-536, Hanney,M.,et al, 2012

The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project
Clin Inf Dis 54:899-904, Gable, M.S.,et al, 2012

Progressive Encephalomyelitis with Rigidity and Myoclonus Gycine and NMDA Receptor Antibodies
Neurol 77:439-443,414, Turner, M.R.,et al, 2011

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Ovarian Germ Cell Tumors: Pathology,Clinical Manifestations,and Diagnosis
UpToDate,Oct, Gershenson,D.M., 2011

Autoimmune encephalitis
BMJ 342:d1918, Irani, S.R.,et all, 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Challenge of the Unknown: A Systematic Review of Acute Encephalitis in Non-Outbreak Situations
Neurol 75:924-932, Granerod,J. et al, 2010

Anti-NMDA Receptor Encephalitis Causing Prolonged Nonconvulsive Status Epilepticus
Neurol 75:1480-1482, Johnson,N.,et al, 2010

Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Arch Neurol 67:118-121, Kurian,M.,et al, 2010

The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Characteristic Behavioral and Movement Disorder
Arch Neurol 67:250-251, Ferioli,S.,et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

NMDA Receptor Encephalitis Mimicking Seronegative Neuromyelitis Optica
Neurol 74:1473-1475, Kruer,M.C., et al, 2010

Retrospective Analysis of NMDA Receptor Antibodies in Encephalitis of Unknown Origin
Neurol 75:1735-1739, Pr�ss,H.,et al, 2010

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Limbic Encephalitis Associated With Antibodies to the NMDA Receptor in Hodgkin Lymphoma
Neurol 73:2039-2040, Zanid,M.S.,et al, 2009

N-Methyl-D-Aspartate Receptor Antibodies in Pediatric Dyskinetic Encephalitis Lethargica
Ann Neurol 66:704-709, Dale,R.,et al, 2009

Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009

Fast-In, Fast-Out
Lancet 373:1398, Hefele,B.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

The Writing on the Wall
Lancet 372:344, Wilder-Smith,E.P. &Ng,E.S., 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Treatment-Responsive Subacute Limbic Encephalitis and NMDA Receptor Antibodies in a Man
Neurol 70:728-729, Novillo-Lopez,M.E.,et al, 2008

Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Neuro-Ophthalmologic Manifestations of Paraneoplastic Syndromes
J Neuro-Ophthalmol 28:58-68, Ko,M.W.,et al, 2008

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Gamma Hydroxybutyrate Intoxication
NEJM 349:1267-1275, Case 30-2003, 2003

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997



Showing articles 100 to 150 of 1206 << Previous Next >>